Patent: 10,034,927
✉ Email this page to a colleague
Summary for Patent: 10,034,927
| Title: | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| Abstract: | The invention relates to the compositions of synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glu-copyranosides conjugated to carriers, and methods for making and use same. |
| Inventor(s): | Gerald B. Pier, Nikolay Nifantiev, Yury Tsvetkov, Marina Gening |
| Assignee: | Brigham and Womens Hospital Inc |
| Application Number: | US15/258,417 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,034,927
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | STRENSIQ | asfotase alfa | Injection | 125513 | October 23, 2015 | 10,034,927 | 2036-09-07 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,034,927
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201101000 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010011284 | ⤷ Start Trial |
| United States of America | 11123416 | ⤷ Start Trial |
| United States of America | 2011150880 | ⤷ Start Trial |
| United States of America | 2014037633 | ⤷ Start Trial |
| United States of America | 2016375117 | ⤷ Start Trial |
| United States of America | 2019117754 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
